Medicare Program spurs increase in mammography screening.
Mammography screening increased following the establishment of the Medicare Shared Savings Program (MSSP), according to a study published in Radiology.
The MSSP was established as part of the Affordable Care Act (ACA), intended to improve the quality of care for Medicare Fee-For-Service beneficiaries while reducing unnecessary costs.
Researchers from Johns Hopkins Hospital in Baltimore, MD, sought to evaluate the impact of accountable care organizations (ACOs) on the use of screening mammography in the MSSP. The researchers evaluated Medicare data on women between the ages of 40 and 69 who underwent screening between 2012 and 2014. Baseline information and the ACO-20 measure (percentage of the women who underwent screening mammography within 24 months) were obtained. A total of 333 ACOs with 5,329,831 Medicare beneficiaries (mean size, 16,006 beneficiaries) participated in the MSSP.
The results showed that screening use varied across ACOs (median, 63.0%), with differences found across regions. The highest use was found in the Midwest (66.6 %) and lowest in the South (58.2%). “A total of 208 ACOs reported longitudinal outcomes, with mean change in screening mammography use of +2.6 percent (range, 233.2 percent to +42.2 percent), with 128 (61.6 percent) ACOs reporting improvements,” the researchers wrote. “No longitudinal differences in use were seen across regions, year of entry, number of beneficiaries, or total composite quality score, nor was there a difference between ACOs that saved money and those that did not.”
“Pay-for-performance incentives in ACOs can facilitate collaboration amongst various stakeholders across the healthcare continuum to improve mammography screening utilization and other key population health metrics, results which will become increasingly relevant as imaging reimbursements transition from fee-for-service to alternative or value-based payment,” study lead author Anand Narayan, MD, PhD, said in a release.
“In radiology, we can take an active role in working with other clinicians to ensure that people get appropriate preventive health services.”
FDA Clears Updated AI Platform for Digital Breast Tomosynthesis
November 12th 2024Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
Is the Kaiser Score More Effective than BI-RADS for Assessing Contrast-Enhanced Mammography and MRI?
October 14th 2024For women with breast-enhanced masses, Kaiser scoring (KS) demonstrated a 20 percent higher AUC than BI-RADS classification for contrast-enhanced mammography (CEM) and was comparable to KS for breast MRI.
FDA Clears New Features in AI-Powered Mammography Software Suite
October 11th 2024Therapixel’s MammoScreen suite has received 510(k) FDA clearances for a breast density assessment feature and updated software that includes automated pre-reporting, which reportedly expedites reporting of mammography findings.